Rất ít bệnh nhân nhiễm biến thể Omicron bị triệu chứng hậu COVID-19

Theo nghiên cứu đăng trên trang newindianexpress.com, sự kết hợp giữa tiêm phòng COVID-19 và triệu chứng nhẹ ở những người nhiễm biến thể Omicron của virus SARS-CoV-2 đã dẫn đến có rất ít bệnh nhân bị các triệu chứng hậu COVID-19 trong làn sóng dịch bệnh mới nhất tại Ấn Độ.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Nga công bố 3 lô vaccine ung thư mRNA đầu tiên

Nga công bố 3 lô vaccine ung thư mRNA đầu tiên

Thế giới
(Baothanhhoa.vn) - Nga vừa giới thiệu 3 lô vaccine ung thư thử nghiệm đầu tiên, được phát triển tại Viện Gamaleya ở Moscow, nơi từng tạo ra vaccine COVID-19 Sputnik V. Đây là loại vaccine điều trị ung thư dựa trên công nghệ mRNA, kết hợp trí tuệ nhân tạo (AI) để tùy...
Time vinh danh “Các kiến trúc sư AI” là Nhân vật của Năm 2025

Time vinh danh “Các kiến trúc sư AI” là Nhân vật của Năm 2025

Thế giới
(Baothanhhoa.vn) - Tạp chí Time đã công bố lựa chọn “Architects of AI” (kiến trúc sư AI) là Nhân vật của năm 2025, nhằm ghi nhận tầm ảnh hưởng ngày càng sâu rộng của AI đối với truyền thông, chính trị, kinh tế và nhiều lĩnh vực khác của đời sống. Đây là lần đầu tiên...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh